Intravitreal triamcinolone for diffuse diabetic macular oedema

Eye

Volumn 20, Issue 6, 2006, Pages 720-724

  Gibran, S K ^a   Cullinane, A ^a   Jungkim, S ^a   Cleary, P E ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

Diffuse diabetic macular oedema; Intravitreal triamcinolone; Refractory diabetic macular oedema

Indexed keywords

CHLORAMPHENICOL; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARGON LASER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MALE; OPTIC NERVE INJURY; OPTICAL COHERENCE TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33745078057     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701992     Document Type: Article

References (19)

1. Chew EY, Ferris III FL. Nonproliferative diabetic retunopathy. In: Ryan SJ (ed). Retina. Mosby Inc.: St Louis, 2001, pp 1295-1308.
2. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema: Long term visual results. Ophthalmology 1991; 98: 1594-1602.
3. Park CH, Jaffe GJ, Fakrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular oedema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136: 419-425.
4. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular oedema. Am J Ophthalmol 2003; 136: 384-386.
5. Saraiva VS, Sallum JM, Farah ME. Treatment of cystoid macular oedema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 2003; 34: 398-400.
6. Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: An optical coherence tomography study. Br J Ophthalmol 2004; 88: 1131-1136.
7. Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR et al. Topography of diabetic macular oedema with optical coherence tomography. Ophthalmology 1998; 105: 360-370.
8. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabeticmacular edema. Am J Ophthalmol 2001; 32: 425-427.
9. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-927.
10. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57-61.
11. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: Preliminary results of a prospective controlled trial. Ophthalmology 2004; 111: 218-224.
12. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters 3rd GB, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after single intravitreal injection. Ophthalmology 2003; 110: 681-685.
13. Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 2004; 111: 2044-2049.
14. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Res Group Diabetes 1998; 47: 1953-1959.
15. Brooks Jr HL, Caballero Jr S, Newell CK. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 2004; 122: 1801-1807.
16. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24-27.
17. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136: 791-796.
18. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003; 23: 686-691.
19. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2004; 122: 1733.